|
1
|
Saslow D, Solomon D, Lawson HW, Killackey
M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur
DC, et al: American cancer society, American society for colposcopy
and cervical pathology, and American society for clinical pathology
screening guidelines for the prevention and early detection of
cervical cancer. J Low Genit Tract Dis. 16:175–204. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kinney W, Wright TC, Dinkelspiel HE,
DeFrancesco M, Cox TJ and Huh W: Increased cervical cancer risk
associated with screening at longer intervals. Obstet Gynecol.
125:311–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schiffman M and Wentzensen N: A suggested
approach to simplify and improve cervical screening in the United
States. J Low Genit Tract Dis. 20:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim JJ, Campos NG, Sy S, Burger EA, Cuzick
J, Castle PE, Hunt WC, Waxman A and Wheeler CM; New Mexico HPV Pap
Registry Steering Committee, : Inefficiencies and high-value
improvements in U.S. cervical cancer screening practice: A
cost-effectiveness analysis. Ann Intern Med. 163:589–597. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Massad LS and Collins YC: Strength of
correlations between colposcopic impression and biopsy histology.
Gynecol Oncol. 89:424–428. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
ASCUS-LSIL Traige Study (ALTS) Group, :
Results of a randomized trial on the management of cytology
interpretations of atypical squamous cells of undetermined
significance. Am J Obstet Gynecol. 188:1383–1392. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
ASCUS-LSIL Traige Study (ALTS) Group, : A
randomized trial on the management of low-grade squamous
intraepithelial lesion cytology interpretations. Am J Obstet
Gynecol. 188:1393–1400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeronimo J and Schiffman M: Colposcopy at
a crossroads. Am J Obstet Gynecol. 195:349–353. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khan MJ, Werner CL, Darragh TM, Guido RS,
Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N,
Massad LS, et al: ASCCP colposcopy standards: Role of colposcopy,
benefits, potential harms, and terminology for colposcopic
practice. J Low Genit Tract Dis. 21:223–229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wentzensen N, Schiffman M, Silver MI, Khan
MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein
MH, et al: ASCCP colposcopy standards: Risk-based colposcopy
practice. J Low Genit Tract Dis. 21:230–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Belinson JL and Pretorius RG: A standard
protocol for the colposcopy exam. J Low Genit Tract Dis.
20:e61–e62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wentzensen N, Walker JL, Gold MA, Smith
KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, et
al: Multiple biopsies and detection of cervical cancer precursors
at colposcopy. J Clin Oncol. 33:83–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
TOMBOLA (Trial Of Management of Borderline
and Other Low-grade Abnormal smears) Group, . Sharp L, Cotton S,
Cochran C, Gray N, Little J, Neal K and Cruickshank M:
After-effects reported by women following colposcopy, cervical
biopsies and LLETZ: Results from the TOMBOLA trial. BJOG.
116:1506–1514. 2009.
|
|
14
|
Stoler MH, Vichnin MD, Ferenczy A, Ferris
DG, Perez G, Paavonen J, Joura EA, Djursing H, Sigurdsson K,
Jefferson L, et al: The accuracy of colposcopic biopsy: Analyses
from the placebo arm of the Gardasil clinical trials. Int J Cancer.
128:1354–1362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huh WK, Papagiannakis E and Gold MA:
Observed colposcopy practice in US community-based clinics: The
retrospective control arm of the IMPROVE-COLPO study. J Low Genit
Tract Dis. 23:110–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cooper CP and Saraiya M: Primary HPV
testing recommendations of US providers, 2015. Prev Med.
105:372–377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soutter WP, Diakomanolis E, Lyons D,
Ghaem-Maghami S, Ajala T, Haidopoulos D, Doumplis D, Kalpaktsoglou
C, Sakellaropoulos G, Soliman S, et al: Dynamic spectral imaging:
Improving colposcopy. Clin Cancer Res. 15:1814–1820. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Louwers JA, Zaal A, Kocken M, Ter Harmsel
W, Graziosi G, Spruijt J, Berkhof J, Balas C, Papagiannakis E,
Snijders P, et al: Dynamic spectral imaging colposcopy: Higher
sensitivity for detection of premalignant cervical lesions. BJOG.
118:309–318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Coronado PJ and Fasero M: Colposcopy
combined with dynamic spectral imaging. A prospective clinical
study. Eur J Obstet Gynecol Reprod Biol. 196:11–16. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaufmann A, Founta C, Papagiannakis E,
Naik R and Fisher A: Standardized digital colposcopy with dynamic
spectral imaging for conservative patient management. Case Rep
Obstet Gynecol. 2017:52692792017.PubMed/NCBI
|
|
21
|
Cholkeri-Singh A, Lavin PT, Olson CG,
Papagiannakis E and Weinberg L: Digital colposcopy with dynamic
spectral imaging for detection of cervical intraepithelial
neoplasia 2+ in low-grade referrals: The IMPROVE-COLPO study. J Low
Genit Tract Dis. 22:21–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
DeNardis SA, Lavin PT, Livingston J,
Salter WR, James-Patrick N, Papagiannakis E, Olson CG and Weinberg
L: Increased detection of precancerous cervical lesions with
adjunctive dynamic spectral imaging. Int J Womens Health.
9:717–725. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Massad LS, Einstein MH, Huh WK, Katki HA,
Kinney WK, Schiffman M, Solomon D, Wentzensen N and Lawson HW; 2012
ASCCP Consensus Guidelines Conference, : 2012 updated consensus
guidelines for the management of abnormal cervical cancer screening
tests and cancer precursors. J Low Genit Tract Dis. 17 (5 Suppl
1):S1–S27. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Castle PE, Stoler MH, Solomon D and
Schiffmanx M: The relationship of community biopsy-diagnosed
cervical intraepithelial neoplasia grade 2 to the quality control
pathology-reviewed diagnoses: An ALTS report. Am J Clin Pathol.
127:805–815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huh WK, Ault KA, Chelmow D, Davey DD,
Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D,
et al: Use of primary high-risk human papillomavirus testing for
cervical cancer screening: Interim clinical guidance. Gynecol
Oncol. 136:178–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schiffman M and Rodríguez AC:
Heterogeneity in CIN3 diagnosis. Lancet Oncol. 9:404–406. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tainio K, Athanasiou A, Tikkinen KAO,
Aaltonen R, Cárdenas J, Hernándes, Glazer-Livson S, Jakobsson M,
Joronen K, Kiviharju M, et al: Clinical course of untreated
cervical intraepithelial neoplasia grade 2 under active
surveillance: Systematic review and meta-analysis. BMJ.
360:k4992018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Demarco M, Lorey TS, Fetterman B, Cheung
LC, Guido RS, Wentzensen N, Kinney WK, Poitras NE, Befano B, Castle
PE and Schiffman M: Risks of CIN 2+, CIN 3+, and cancer by cytology
and human papillomavirus status: The foundation of risk-based
cervical screening guidelines. J Low Genit Tract Dis. 21:261–267.
2017. View Article : Google Scholar : PubMed/NCBI
|
